BIOFILCHEM2024-10-012024-12-31 BIOFILCHEM2024-10-012024-12-31 BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneOperatingExpenses03Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourOperatingExpenses03Member BIOFILCHEM2024-12-31 BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member BIOFILCHEM2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member BIOFILCHEM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member BIOFILCHEM2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524396 BIOFILCHEM NOTLISTED Biofil Chemicals & Pharmaceuticals Limited Equity 2024-04-01 2025-03-31 2025-02-11 2025-02-04 INR Lakhs Third quarter 15:00:00 17:15:00 2025-02-11 2025-02-11 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Standalone 141952000.00 230000.00 142182000.00 21312000.00 82335000.00 31461000.00 2145000.00 98000.00 987000.00 1628000.00 139966000.00 2216000.00 0.00 2216000.00 571000.00 0.00 571000.00 0.00 1645000.00 0.00 0.00 0.00 0.00 1645000.00 0.00 1645000.00 0.00 0.00 162738000.00 10 0.10 0.10 0.00 0.00 0.10 0.10 1 The above unaudited financial results for the Quarter and nine month ended December 31, 2024 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on February 11, 2025. The above results have been reviewed by statutory Auditors of the company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, who have expressed an unmodified opinion. The Company's Management has exercised necessary due diligence to ensure that the financial results provide a true and fair view of its affairs. 2 This statement has been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. 3 The Company has reported segment wise information as per Indian Accounting Standard (Ind AS-108). The Operations of the Company are conducted within India, there is no separate reportable geographical segment and the company reported the following business segments a. Pharma Division b. Chemicals Division. 4 The figures of the previous period / year have been re-stated/ re-grouped / re-arranged/ reclassified and / or recasted wherever found necessary. 5 The aforesaid un-audited financial Results will be uploaded on the Company’s website www.biofilgroup.net and will also be available on the websites of the Stock exchanges i.e. www.bseindia.com and www.nseindia.com for the benefit of shareholders and investors. Multi segment 2024-04-01 2024-12-31 Unaudited Standalone 250512000.00 685000.00 251197000.00 32390000.00 210647000.00 -11081000.00 5361000.00 294000.00 2962000.00 5801000.00 246374000.00 4823000.00 0.00 4823000.00 1242000.00 0.00 1242000.00 0.00 3581000.00 0.00 0.00 0.00 0.00 3581000.00 0.00 3581000.00 0.00 0.00 162738000.00 10 0.22 0.22 0.00 0.00 0.22 0.22 Administrative Expenses 462000.00 Manufacturing Expenses 1119000.00 Selling and Distribution Expenses 47000.00 Administrative Expenses 2067000.00 Manufacturing Expenses 3112000.00 Selling and Distribution Expenses 622000.00 Chemicals Division 21475000.00 Pharma Unit 120477000.00 Chemicals Division 37852000.00 Pharma Unit 212660000.00 141952000.00 250512000.00 141952000.00 250512000.00 Chemicals Division 2541000.00 Pharma Unit -234000.00 Chemicals Division 5830000.00 Pharma Unit -740000.00 2307000.00 5090000.00 91000.00 267000.00 2216000.00 4823000.00 Chemicals Division 147895000.00 Pharma Unit 304003000.00 451898000.00 Chemicals Division 17941000.00 Pharma Unit 248346000.00 266287000.00